The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.

 
Web www.patentalert.com

< Certain 9-aza-bicyclo[3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

> Tetrahydrothiopyrano pyrazole cannabinoid modulators

> Compounds useful for the treatment of diseases
~ 00565